The Polish Competition Authority clears a merger in the pharmaceuticals sector, subject to a divestment remedy (Sanofi-Synthelabo / Aventis)

The operation The acquisition of Aventis by Sanofi-Synthelabo was performed by a public bid. The President of the OCCP, on 18 May 2004, cleared the merger, which led to the establishment of one of the largest pharmaceutical groups in the world (pages 3-5). The market(s) The President of the OCCP assessed that the proposed concentration would horizontally affect the pharmaceutical

L'accès à cet article est réservé aux abonnés

Déjà abonné ? Identifiez-vous

L’accès à cet article est réservé aux abonnés.

Lire gratuitement un article

Vous pouvez lire cet article gratuitement en vous inscrivant.

 

Version PDF

Auteur

Citation

Marcin Bartnicki, The Polish Competition Authority clears a merger in the pharmaceuticals sector, subject to a divestment remedy (Sanofi-Synthelabo / Aventis), 18 mai 2004, e-Competitions May 2004, Art. N° 21046

Visites 2513

Tous les numéros

  • Latest News issue 
  • Tous les News issues
  • Latest Special issue 
  • Tous les Special issues